https://www.selleckchem.com/pr....oducts/BafilomycinA1
HLH and hypopituitarism were considered secondary to IVL. All her clinical findings matched the presentations of IVL. She was immediately treated with chemotherapy and achieved complete response. She was relapse free two years after treatment. IVL should be included in the differential diagnosis of hypopituitarism, which although life-threatening, is treatable through prompt diagnosis and appropriate chemotherapy. IVL should be included in the differential diagnosis of hypopituitarism, which although life-threatening, is treatable